Harbinger Times

Sjogren’s Syndrome Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight

Sjogren’s Syndrome Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight

The Sjogren’s Syndrome clinical trial analysis report delivers important insights into ongoing research of 18+ pipeline Sjogren’s Syndrome drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October

Read Full Article

IgA Nephropathy Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight

The IgA Nephropathy clinical trial analysis report delivers important insights into ongoing research of 25+ pipeline IgA Nephropathy drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October

Read Full Article

Influenza Clinical Trial Drug Development Pipeline Expands with Contributions from 120+ Key Companies | DelveInsight

The Influenza clinical trial analysis report delivers important insights into ongoing research on 120+ pipeline Influenza Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October 08, 2026,

Read Full Article

the Nontuberculous Mycobacteria Infections Treatment Market Size in the 7MM was more than USD 750 million in 2025 and It is projected to grow at a CAGR of 12.6% by 2036

The Nontuberculous Mycobacterial market report delivers important insights into ongoing research on Nontuberculous Mycobacterial Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) On October 08, 2026, DelveInsight’s “Nontuberculous

Read Full Article

Performance Roofing & Siding Celebrates Pontiac’s First Hauntiac Parade

Performance Roofing & Siding celebrated Pontiac’s inaugural Hauntiac Parade on October 3 with a festive ghost-and-goblin display. Performance Roofing &

Read Full Article

Thyroid Eye Disease Market Set to Witness Growth with Rising Awareness, Early Diagnosis, and Emerging Targeted Therapies by 2034 – DelveInsight | Immunovant Sciences, Viridian Therapeutics, Novartis

The Key Thyroid Eye Disease Companies in the market include – Horizon Therapeutics, Immunovant Sciences, Viridian Therapeutics, Novartis Pharmaceuticals, Sling

Read Full Article

Anesthesia Machines Market to Reach USD 34.40 Billion by 2034, Driven by Rising Surgical Volumes, Ambulatory Surgical Center Expansion, and AI-Enabled Anesthesia Platforms

Key Anesthesia Machines companies such as Shenzhen Comen Medical Instruments Co., Ltd., SternMed GmbH, General Electric Company, Koninklijke Philips N.V.,

Read Full Article

Congenital Hyperinsulinism Market to Grow at 12% CAGR Through 2036, Driven by Advancements in Targeted Therapies and Increasing Diagnosis | DelveInsight

The market dynamics for Congenital Hyperinsulinism (CHI) are witnessing significant growth, driven by increasing disease awareness, advancements in genetic testing,

Read Full Article

Hereditary Transthyretin Amyloidosis Market is Projected to Reach USD 3 Billion by 2025 and Grow at 11% CAGR Through 2036 Owing to Advancements in RNA-based and Gene-Editing Therapies | DelveInsight

The market dynamics for Hereditary Transthyretin Amyloidosis (hATTR) are witnessing robust growth driven by increasing disease awareness, improvements in genetic

Read Full Article

Multiple Sclerosis Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight

The Multiple Sclerosis clinical trial analysis report delivers important insights into ongoing research on 75+ pipeline Multiple Sclerosis Drugs, clinical

Read Full Article

Categories